4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-003006
Director sold 5,000 shares at an average $56.30 ($281,517)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Jeffrey William Director | 2025-02-03 | Sale 10b5-1 | −1,100 | $55.94 | $61,537 | 42,511 | D: show line 1 in the form |
| Henderson Jeffrey William Director | 2025-02-03 | Sale 10b5-1 | −3,900 | $56.41 | $219,980 | 38,611 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $56.30 · $281,517 | |||||||
Loading xslF345X05/form4-02042025_110227.xml…